Innoviz Technologies Announces Registered Direct Offering
Ticker: INVZW · Form: 6-K · Filed: Feb 12, 2025 · CIK: 1835654
| Field | Detail |
|---|---|
| Company | Innoviz Technologies LTD. (INVZW) |
| Form Type | 6-K |
| Filed Date | Feb 12, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $1.39, $37.3 m, $1.69, $40 Million |
| Sentiment | neutral |
Sentiment: neutral
Topics: offering, capital-raise, securities
TL;DR
Innoviz is selling shares to investors, raising cash.
AI Summary
On February 10, 2025, Innoviz Technologies Ltd. entered into a securities purchase agreement with certain institutional investors to sell shares in a registered direct offering. The filing does not specify the number of shares or the total dollar amount of the offering.
Why It Matters
This offering indicates Innoviz is raising capital, which could be for expansion, R&D, or to cover operational costs.
Risk Assessment
Risk Level: medium — Direct offerings can dilute existing shareholders and signal a need for immediate capital, potentially due to financial pressures.
Key Players & Entities
- Innoviz Technologies Ltd. (company) — Registrant and issuer of securities
- February 10, 2025 (date) — Date of securities purchase agreement
- Securities Purchase Agreement (document) — Agreement for the direct offering
- institutional investors (company) — Purchasers of the securities
FAQ
What is the total dollar amount of the registered direct offering?
The filing states that Innoviz Technologies Ltd. agreed to sell shares but does not specify the total dollar amount of the offering.
How many shares is Innoviz Technologies Ltd. selling in this offering?
The filing does not specify the number of shares being sold in the registered direct offering.
Who are the specific institutional investors purchasing shares?
The filing refers to 'certain institutional investors' as the purchasers but does not name them.
What is the intended use of the proceeds from this offering?
The filing does not disclose the intended use of the proceeds from the registered direct offering.
What is the price per share for this registered direct offering?
The filing does not mention the price per share for the securities being offered.
Filing Stats: 1,280 words · 5 min read · ~4 pages · Grade level 12.3 · Accepted 2025-02-12 09:19:56
Key Financial Figures
- $1.39 — o the Purchasers at a purchase price of $1.39 per unit, with each unit consisting of
- $37.3 m — received net proceeds of approximately $37.3 million, after deducting the placement ag
- $1.69 — warrants are immediately exercisable at $1.69 per share and will expire on February 1
- $40 Million — entitled "Innoviz Announces Pricing of $40 Million Registered Direct Offering" is furnishe
Filing Documents
- zk2532700.htm (6-K) — 20KB
- exhibit_4-1.htm (EX-4.1) — 96KB
- exhibit_5-1.htm (EX-5) — 9KB
- exhibit_5-2.htm (EX-5.1) — 13KB
- exhibit_10-1.htm (EX-99) — 181KB
- exhibit_99-1.htm (EX-99.1) — 7KB
- im2.jpg (GRAPHIC) — 15KB
- image1.jpg (GRAPHIC) — 149KB
- image00002.jpg (GRAPHIC) — 40KB
- 0001178913-25-000427.txt ( ) — 608KB
Forward-Looking Statements
Forward-Looking Statements: This Report includes forward-looking statements within the meaning of the federal securities laws, including statements regarding the completion and timing of the offering and the intended use of the proceeds. Forward-looking statements represent Innoviz's current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking agreement related to the offering. The forward-looking statements included in this Report speak only as of the date of this Report, and Innoviz does not undertake to update the statements included in this Report for subsequent developments, except as may be required by law. The Company hereby furnishes the following documents as Exhibits 4.1, 5.1, 5.2, 10.1, 23.1, 23.2 and 99.1. Exhibit No. Description 4.1 Form of Warrant. 5.1 Opinion of Naschitz, Brandes, Amir & Co., Advocates as to the validity of the ordinary shares. 5.2 Opinion of Latham & Watkins LLP as to the validity of the warrants. 10.1 Form of Securities Purchase Agreement. 23.1 Consent of Naschitz, Brandes, Amir & Co., Advocates (included in Exhibit 5.1). 23.2 Consent of Latham & Watkins LLP (included in Exhibit 5.2). 99.1 Press Release dated February 10, 2025.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Innoviz Technologies Ltd. By: /s/ Eldar Cegla Name: Eldar Cegla Title: Chief Financial Officer Date: February 12, 2025